All Stories

  1. Recombinant factor XIII prophylaxis is safe and effective in young children with congenital factor XIII-A deficiency: international phase 3b trial results

    Article • Journal of Thrombosis and Haemostasis, July 2017, Wiley

    Bryce Kerlin

  2. Thrombin-Induced Podocyte Injury Is Protease-Activated Receptor Dependent

    Article • Journal of the American Society of Nephrology, April 2017, American Society of Nephrology

    Bryce Kerlin

  3. AKI in Children Hospitalized with Nephrotic Syndrome

    Article • Clinical Journal of the American Society of Nephrology, October 2015, American Society of Nephrology

    Dr Michelle Rheault, Dr Rasheed A Gbadegesin, Bryce Kerlin, Dr David T Selewski, Isa Ashoor

  4. Pharmacokinetics of recombinant factor XIII at steady state in patients with congenital factor XIII A-subunit deficiency

    Article • Journal of Thrombosis and Haemostasis, October 2014, Wiley

    Bryce Kerlin

  5. Epidemiology and Pathophysiology of Nephrotic Syndrome-Associated Thromboembolic Disease

    Article • Clinical Journal of the American Society of Nephrology, February 2012, American Society of Nephrology

    Bryce Kerlin